Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Related Quality of Life Questionnaire Specific to Dysthyroid Ophthalmopathy Evaluated in a Population of Patients With Graves’ Disease
source: Archives of Endocrinology and Metabolism
year: 2017
authors: Delfino LC, Zunino A, Sapia V, Croome MDCS, Ilera V, Gauna AT
summary/abstract:Objective:
The aim of this study was to measure quality of life (QOL) impairment in individuals currently suffering from Graves’ ophthalmopathy (GO) and to determine the correlation of GO-specific QOL scores with disease severity and activity.
Subjects and Methods:
Seventy three GO-specific QOL surveys were prospectively analysed and compared with GO status. The GO-specific QOL survey was translated into Spanish and applied to Argentine patients with Graves’ disease (GD). Results were compared with presence or absence of GO, Clinical Activity Score (CAS), severity score, age, gender and thyroid function.
Results:
Fifty-six patients answered the survey and underwent complete ophthalmic evaluation, 15 did not have GO and were considered to be a control group. Appearance QOL score for patients with GO (53 ± 31.4) was lower than the control group (88.3 ± 17) (p < 0,000), no difference was observed in functional QOL score. There was a negative correlation between GO severity and both functional (r = -0.575; p < 0.000) and appearance QOL (r = -0.577; p < 0.000). Functional QOL differed between patients with active GO vs control group (p = 0.043). Patients with active and inactive GO had lower appearance QOL scores than control group (p < 0.000, p < 0.001 respectively).
Conclusions:
GO has significant impact on the life of these Argentine patients. QOL was worse in GO patients than in control group, functional QOL was mostly affected by the activity and appearance QOL was mainly altered by the effects of the disease. Patients with more severe GO had lower scores on both QOL scales.
DOI: 10.1590/2359-3997000000252
read more full text
Related Content
-
FDA Committee Unanimously Recommends Approval of Teprotumumab for Thyroid Eye DiseaseThe Dermatologic and Ophthalmic Drugs Ad...
-
Cardiovascular Complications Secondary to Graves’ Disease: A Prospective Study from UkraineBackground: Graves' disease (GD) is a c...
-
International Symposium on Graves’ OrbitopathyThe EUGOGO 20th Anniversary Meeting prog...
-
Graves’ and Thyroid Eye Disease Support Group MeetingThis event is hosted by Graves' Dise...
-
Gut Microbes May Play Role in Graves ’ Disease Diagnosis, Thyroid AutoimmunityThe abundance and diversity of intestina...
-
Efficacy of Orbital Radiotherapy in Moderate-to-Severe Active Graves’ Orbitopathy Including Long-Lasting Disease: ...Background: We aimed to explore the eff...
-
Evaluation of Quality of Life in Patients With Graves´ Ophthalmopathy, Before and After Orbital DecompressionGraves' ophthalmopathy (GO) is a potenti...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.